Keyword Search Year None202420232022202120202019201820172016201520142013 May 08, 2024 Labcorp to Webcast Its Annual Meeting of Shareholders Read more » May 07, 2024 Invitae Receives Court Approval for Sale to Labcorp Read more » Apr 29, 2024 Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B Read more » Apr 25, 2024 Labcorp Announces 2024 First Quarter Results Read more » Apr 24, 2024 Labcorp Announces Winning Bid for Select Assets of Invitae Read more » Apr 15, 2024 Labcorp Announces First-of-Its-Kind Test for Early Indication of Neurodegenerative Diseases and Brain Injuries Using a Blood Draw Read more » Apr 11, 2024 Labcorp Declares Quarterly Dividend Read more » Apr 10, 2024 Labcorp Receives FDA Emergency Use Authorization for Mpox PCR Test Home Collection Kit Read more » Apr 08, 2024 Labcorp Announces Expansion of Precision Oncology Portfolio to Support Pharmaceutical, Biopharma, and Clinical Research in Advancing Drug Development Programs Read more » Apr 05, 2024 Labcorp Launches Labcorp® Plasma Detect™ Extending Leadership into Molecular Residual Disease (MRD) Clinical Research Read more » Apr 02, 2024 Labcorp to Present Diverse Portfolio of Precision Oncology Research at the Annual Meeting of the American Association for Cancer Research Read more » Mar 28, 2024 Labcorp Announces Acquisition of Select Assets of BioReference Health's Diagnostics Business Read more » Mar 27, 2024 Labcorp to Announce First Quarter Financial Results on April 25, 2024 Read more » Mar 20, 2024 Labcorp Launches pTau217 Blood Biomarker Test to Accelerate Path to Diagnosis of Alzheimer's Disease and Support Clinical Trials Read more » Mar 16, 2024 Labcorp Presents New Research Demonstrating Clinical Impact of Precision Diagnostics in Guiding Biomarker-targeted Therapies for Patients with Epithelial Ovarian Cancer Read more » Mar 07, 2024 Labcorp Launches Weight Loss Management Testing Solutions Read more » Feb 15, 2024 Labcorp Announces 2023 Fourth Quarter and Full Year Results Read more » Feb 01, 2024 Labcorp Named One of the World's Most Admired Companies™ by FORTUNE® Magazine Read more » Jan 31, 2024 Labcorp Launches New Test for Risk Assessment and Prognosis of Severe Preeclampsia in Pregnant Women Read more » Jan 16, 2024 Labcorp to Announce Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024 Read more » Jan 12, 2024 Labcorp Declares Quarterly Dividend Read more » Jan 10, 2024 Labcorp and Hawthorne Effect Collaborate to Bring Clinical Trials Directly to Patients and Investigators in Local Communities Read more » Jan 02, 2024 Labcorp to Speak at the 42nd Annual J.P. Morgan Healthcare Conference Read more » First page « first Previous page ‹ previous Page 1 Current page 2
